Brief: Reviva Pharmaceuticals Holdings Reports Q2 2022 Results And Recent Business Highlights

Reviva Pharmaceuticals Holdings

15/08/2022 22:15

Aug 15 (Reuters) - Reviva Pharmaceuticals Holdings, Inc.
 RVPH.O :
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. REPORTS SECOND
QUARTER
2022 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * REVIVA PHARMACEUTICALS - BELIEVES CO'S CASH AS OF JUNE 30,
2022
SUFFICIENT TO FUND CURRENT OPERATING PLANS THROUGH AT LEAST
MARCH 2023
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. - AS OF JUNE 30,
2022,
CO'S CASH TOTALED ABOUT $19.4 MILLION COMPARED TO ABOUT $29.7
MILLION AS OF DECEMBER 31, 2021
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. - QTRLY LOSS PER
SHARE
$0.29

Source text for Eikon:  ID:nGNX12QhYK 
Further company coverage:  RVPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))